Elliott F Winton MD

Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 18

  1. 1
  2. 2

Article

Ruxolitinib: a steroid sparing agent in chronic graft-versus-host disease

by Hanna Khoury; Amelia Langston; Vamsi Kota; Jennifer A. Wilkinson; Iskra Pusic; Anand Jillella; Stephanie Bauer; Audrey S Kim; Danielle Roberts; Zaid Al-Kadhimi; Imre Bodo; Elliott Winton; Martha Arellano; John F. DiPersio

2018

Article

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

by Claire N Harrison; Nicolaas Schaap; Alessandro M Vannucchi; Jean-Jacques Kiladjian; Ramon V Tiu; Pierre Zachee; Eric Jourdan; Elliott Winton; Richard T Silver; Harry C Schouten; Francesco Passamonti; Sonja Zweegman; Moshe Talpaz; Joanne Lager; Zhenming Shun; RA Mesa

2017

Article

A randomized phase 3 trial of interferon-alpha vs hydroxyurea in polycythemia vera and essential thrombocythemia

by John Mascarenhas; Heidi E Kosiorek; Josef T Prchal; Alessandro Rambaldi; Dmitriy Berenzon; Abdulraheeem Yacoub; Claire N Harrison; Mary Frances McMullin; Alessandro M Vannucchi; Joanne Ewing; Casey L O'Connell; Jean-Jacques Kiladjian; Adam J Mead; Elliott Winton; David S Leibowitz; Valerio De Stefano; Murat O Arcasoy; Craig M Kessler; Rosalind Catchatourian; Damiano Rondelli; Richard T Silver; Andrea Bacigalupo; Arnon Nagler; Marina Kremyanskaya; Max F Levine; Juan Arango E Ossa; Erin McGovern; Lonette Sandy; Mohamad E Salama; Vesna Najfeld; Joseph Tripodi; Noushin Farnoud; Alexander Penson; Rona Singer Weinberg; Leah Price; Judith D Goldberg; Tiziano Barbui; Roberto Marchioli; Gianni Tognoni; Raajit K Rampal; Ruben A Mesa; Amylou C Dueck; Ronald Hoffman

2022

Article

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

by Daniel J DeAngelo; Deepi H Radia; Tracy I George; William A Robinson; Albert T Quiery; Mark W Drummond; Prithviraj Bose; Elizabeth O Hexner; Elliott Winton; Hans-Peter Horny; Meera Tugnait; Oleg Schmidt-Kittler; Erica K Evans; Hui-Min Lin; Brenton G Mar; Srdan Verstovsek; Michael W Deininger; Jason Gotlib

2021

Article

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia

by Anand P Jillella; Martha Arellano; Manila Gaddh; Amelia Langston; Leonard T Heffner; Elliott Winton; Morgan McLemore; Chao Zhang; Catherine R Caprara; Kathryn S Simon; Sheldon L Bolds; Stephanie DeBragga; Prachi Karkhanis; Shruthi H Krishnamurthy; Jose Tongol; Mohamed M El Geneidy; Asim Pati; Jonathan M Gerber; Michael R Grunwald; Jorge Cortes; Asad Bashey; Robert K Stuart; Vamsi Kota

2021

Article

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

by Alexander Coltoff; Ruben Mesa; Jason Gotlib; Jessica Shulman; Raajit K Rampal; Olivia Siwoski; Abdulraheem Yacoub; Alison Moliterno; Anna Yang; Evan Braunstein; Aaron T Gerds; Gabriela S Hobbs; Elliott Winton; Swati Goel; Martha Wadleigh; Douglas Tremblay; Erin Moshier; John Mascarenhas

2020

Article

Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.

by John O. Mascarenhas; Moshe Talpaz; Vikas Gupta; Lynda M. Foltz; Michael R. Savona; Ronald Paquette; A. Robert Turner; Paul Coughlin; Elliott Winton; Timothy C. Burn; Peter O'Neill; Jason Clark; Deborah Hunter; Albert Assad; Ronald Hoffman; Srdan Verstovsek

2017

Article

Long-term Treatment With Rituximab of Autoimmune Autonomic Ganglionopathy in a Patient With Lymphoma

by Ryan Hollenbeck; Bonnie K. Black; Amanda C. Peltier; Italo Biaggioni; David Robertson; Elliott Winton; Satish R. Raj

2011

Article

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

by Ruben A. Mesa; Jason Gotlib; Vikas Gupta; John V. Catalano; Michael W. Deininger; Alan L. Shields; Carole B. Miller; Richard T. Silver; Moshe Talpaz; Elliott Winton; Jimmie H. Harvey; Thomas Hare; Susan Erickson-Viitanen; William Sun; Victor Sandor; Richard S. Levy; Hagop M. Kantarjian; Srdan Verstovsek

2013

Article

The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis

by Srdan Verstovsek; Ruben A. Mesa; Jason Gotlib; Richard S. Levy; Vikas Gupta; John F. DiPersio; John V. Catalano; Michael Deininger; Carole Miller; Richard T. Silver; Moshe Talpaz; Elliott F Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth Hexner; Roger M. Lyons; Ronald Paquette; Azra Raza; Kris Vaddi; Susan Erickson-Viitanen; William Sun; Victor Sandor; Hagop M. Kantarjian

2013